Formulation and evaulation of triazolam odts by direct compression forselection & optimization of super disintegrates


  • Sudhakar Kancharla Director Clinical Laboratory, Devansh Lab Werks,234, Aquarius Drive, Homewood, Alabama, USA-3520.
  • Prachetha Kolli Scientist, Microgen Health Inc, 14225,Sullyfield Cir Suite E, Chantilly, VA, USA-2015.
  • Dr.K.Venkata Gopaiah Associate Professor, St. Mary’s College of Pharmacy, Chebrolu, Guntur-A.P-522 212-India



Triazolam, Oral Disintegrating


Oral Disintegrating Tablets of Triazolam were formulated with an aim to improve the versatility, patient compliance, and accurate dosing. The formulations ere developed with an objective to use by the pediatric and geriatric patients. Triazolam Oral Disintegrating Tablets were prepared by direct compression method using cross povidone, croscarmellose sodium, sodium starch  glycolate and combinations of CP+CCS, and CP + SSG as super disintegrates exhibited good pre-formulation and tableting properties of three super disintegrates, the formulation contained combination of CP + CCS showed better performance in terms of disintegration time when compared to other formulations. Order of the super disintegrates activity is as follows.

(CP + CCS) > (CP + SSG) > CP > CCS >SSG

The formulation F15 was found to be the best among all twenty Triazolam ODT formulations because it has exhibited faster disintegration time (17.66 sec) when compared to the other formulations and it showed 99.87±0.18% drug release at the end of 25 min. Triazolam Oral Disintegrating Films were prepared by solvent casting method using different grades of Hydroxypropyl Methyl Cellulose like HPMC – E15, HPMC – 5cps, HPMC – 50cps. Based on disintegration and dissolution results it was concluded that the formulation F15 contained CP 5% + CCS 5% was the best formulation among all otherformulations.


Download data is not yet available.


Alpesh R. Patel.; Dharmendra S.; Prajapati, Jignyasha A.; Raval, fast dissolving films (fdfs) as a newer venture in fast dissolving dosage forms, International Journal of Drug Development & Research. 2(2), 316-246,2010.

Dixit RP.; Puthli SP. Oral strip technology: Overview and future potential. J. Control.Release. 139(2), 94-10,2009.

Suresh Bandari.; RajenderkumarMittapalli.; Ramesh Gannu.; MadhusudanRao Y. Orol dispersible tablets: An overview. Asian J Pharm., 2(1), 2-11,2008.

Parakh S.R, Gothoskar A.V: A review of mouth dissolving tablet technologies. Pharm. Tech., 27(11): 92-98,2003.

Guidance for Industry Orally Disintegrating Tablets published by centre for drug evolution and research, accessed at

Rakesh Pahwa, Mona Piplani, Prabodh C. Sharma, DhirenderKaushik and Sanju Nanda. Orally Disintegrating Tablets – Friendly to Pediatrics and Geriatrics. Archives of Applied Science Research: 2 (2), 35 – 48,2010.

Tejvir Kaur, Bhawandeep Gill, Sandeep Kumar, and G.D. Guptha. Mouth Dissolving Tablets: A Novel Approach to Drug Delivery, Vol – 3, issue 1,2011.

A Guptha, AK Mishra, V Guptha, P Bansal, R Singh, AK Singh. Recent Trends of Fast Dissolving Tablet – An Overview of Formulation Technology. International Journal of Pharmaceutical & Biological Archieves: 1 (1), 1 – 10,2010.

DebjitBhowmik, Chiranjib.B, Krishnakanth, Pankaj, R.MargretChandira. Fast Dissolving Tablets: An Overiew. Journal of Chemical and Pharmacetical Research: 1(1), 163 – 177,2009.

William R.P. Fister, TapashK. Ghosh. Orally disintegrating tablets. Pharmaceutical Technology (Product, Technologies and Development issues in Oct2005).

Manoj Ashok Wagh, KothawadeParagDilip, KishorSahebraoSalunkhe, Nayana Vijay Chavan, VandanaRadheshyamDaga. Techniques used in orally disintegrating drug delivery system. International Journal of Drug Delivery: 2, 98 – 107,2010.

Rosie Mc Laughlin, Susan Banbury, and Kieran Crowley. Supplement to Pharmaceutcial technology: Orally Disintegrating Tablets – The Effect of Recent FDA Guidance on ODT Technologies and Applications.2009.

DebjithBhowmik, Chiranjib, JyotiJaiswal, Vinod Dubey, Margret Chanira. Fast Dissolving Tablets: A review on revolution of novel drug delivery system and new market opportunities. Der Pharmacia Lettre: 1 (2), 262 – 276,2009.

Honey Goel, ParshuramRai, VikasRana, and Ashok k. Tiwary. Orally Disintegrating Systems: Innovations in Formulation and Technology. Recent Patents on drug delivery & formulation: 2, 258 – 274,2008.

Bupendra G Prajapathi and NayanRatnakar. A Review on Recent patents on Fast Dissolving Drug Delivery System. International Journal of PharmTech Research: 1(3), 790 – 798,2009.

Dobetti L: Fast-Melting Tablets: Developments and Technologies. Pharm. Technol., Drug delivery supplement, 44-50,2001.

Yarwood R: Zydis– A novel, Fast Dissolving Dosage Form. Man. Chem., 61: 36-37,1990.

Kuldeepak Sharma, William R. Pfister, and TapashK. Ghosh, Drug Delivery to the Oral Cavity, Quick – Dispersing Oral Drug Delivery Systems, 261 – 289,2005.

R. Margret Chandra, B.S. Venkateshwarlu, M. V. Kumudhavalli, DebjitBhowmik, Dr. B. Jayakar. Formualation and Evaluation of the Fast Dissolving Tablets of Aceclofenac. The Pharma Review: 164 – 167,2008.

Suhas M. Kakade, Vinodh S. Mannur, Ketan B. Ramani, AyazA. Dhada, Chirag V. Naval, AvinashBhagwat Formulation and Evaluation of Mouth dissolving tabletsof Losartan potassium by direct compression techniques, Int. J. Res. Pharm. Sci, Vol-1, Issue-3, 2010,pp:290-295.

Makino T, Yamada M, Kikuta J.I: Fast dissolving tablet and its production. US Patent No. 5,720,974,1998.

Bi Y: Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull., 44 (11): 2121-2127,1996.

Vijaya K.S.G and Mishra D. N.Rapidly Disintegrating Oral Tablets of Meloxicam. Indian Drugs: 43(2) 117 – 122,2006.

Watanabe Y: New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol. Pharm. Bull., 18 (9): 1308-1310,1995.

Ito A, Sugihara M: Development of oral dosage form for elderly patients: Use of agar as base of rapidly disintegrating oral tablets. Chem. Pharm. Bull., 44 (11): 2132-2136,1996.

Uday S Rangole, PS Kawtikwar and DM Sakarkar, Formulation and In - vitro Evaluation of Rapidly Disintegrating Tablets using Hydrochlorothiazide as a model drug, Research J. Pharm and Tech, 349 – 352,2008.

Dali Shukla, Subhashis Chakraborty, Sanjiv Singh, Brahmeshwar Mishra. Mouth Dissolving Tablets II: An Overview of Evaluation Techniques. Sci Pharm: 77, 327 – 341,2009.

Shirwaikar A.A: Fast Disintegrating Tablets of Atenolol by Dry Granulation Method. Ind. J. Pharm. Sci., 66(4): 422-426,2004.

El-Arini S.K, Clas S.D: Evaluation of Disintegration Testing of Different Fast Dissolving Tablets Using Texture Analyzer. Pharm. Dev. Tech., 7(3): 361- 371,2002.

Morita Y, Tsuhima Y, Yasui M, Termoz R, Ajioka J, TakayamK. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing CCD camera. Chem. Pharm. Bull; 50 (9):1181-1186,2002.

Nazaraki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull; 52(6): 704- 707,2004.

Dor J.M.P, Fix J.A: In-vitro determination of disintegration time of quick dissolve tablets using a new method. Pharm. Dev. Tech., 5(4): 575-577,2000.

James Klancke: Dissolution testing of orally disintegrating tablets. Dissolution technologies, 10(2): 6-8,2003.

BorsadiaS.B,O’HalloranD,OsborneJ.L:Oral film technology: Quick dissolvingfilms.

Barnhart SD.; Sloboda MS, Dissolvable films the future of dissolvable films.DrugDev tech. 1, 34-35,2007.

Vondrak B.; Barnhart S.; Dissolvable Films for Flexible Product Format in Drug Delivery, Pharmaceutical Technology Supplement. April2008.

Frey P.; Film Strips and Pharmaceuticals,Pharma. Mfg. &Packag.Sourcer, winter, 92- 93,2006.

Zhang H.; Zhang J.; Streisand J.B. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications, Clin. Pharmacokinet, 41 (9), 661-680,2002.

Chang R. K.; Guo X.; Burnside B. A.; Couch R. A. Pharma. Tech. 24(6), 52-58,2000.

Repka M.; et al., "Hot melt extrusion", in J. Swarbrick and J. Boylan, Eds., Encyclopedia of Pharmaceutical Technology, Volume 2, 2nd Edition (Marcel Dekker Inc, New York, NY USA, 1488–1504,2002.

United States Patent No: 5648093; Gole et al; titled ‘ Pharmaceuticalandother dosage forms’;1997.

Hoffmann & baron, llp(6900 jericho turnpike, syosset, ny, 11791, us) United States Patent Application20080226695.

Barnhart SD.; Sloboda MS.; Dissolvable films the future of dissolvable films. Drug Dev tech. 1, 34-35,2007.

Guidance for Industry: Orally Disintegrating Tablets, Center for Drug Evaluation and Research (Centre for Drug Evaluation and Research, CDER) US FDA,2008. may2004.

Renuka Mishra.; Avaniamin, Pharmaceutica, Technology, 33(2), 48- 56,2009.


70 Views | 66 Downloads

How to Cite

Kancharla, S. ., P. Kolli, and D. . Gopaiah. “Formulation and Evaulation of Triazolam Odts by Direct Compression Forselection & Optimization of Super Disintegrates ”. International Journal of Pharmaceutics and Drug Analysis, vol. 9, no. 1, Mar. 2021, pp. 36-45, doi:10.47957/ijpda.v9i1.456.



Research Articles
Share |